106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies, at GuidelineCentral.com
Copyright © 2016 All rights reserved
SVSLE16052b
Disclaimer
is Guideline attempts to define principles of practice that should produce high-quality
patient care. It focuses on the needs of primary care practice, but also is applicable to providers
at all levels. is Guideline should not be considered exclusive of other methods of care
reasonably directed at obtaining the same results. e ultimate judgment concerning the
propriety of any course of conduct must be made by the clinician aer consideration of each
individual patient situation.
Neither IGC, the medical associations, nor the authors endorse any product or service
associated with the distributor of this clinical reference tool.
Source
Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL,
Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN; Society for Vascular Surgery.
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of
the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg.
2015;61(3 Suppl):2S-41S.
Abbreviations
ABI, ankle-brachial index; ACEI, Angiotensin-converting enzyme inhibitor; AIOD,
aortoiliac occlusive disease; BMS, bare-metal stent; CFA, common femoral artery; CT,
computed tomography; CTA, computed tomography angiography; MRA, magnetic
resonance angiography; CV, cardiovascular; EVT, endovascular therapy; FPOD,
femoropopliteal occlusive disease; IC, intermittent claudication; MI, myocardial
infarction; PAD, peripheral arterial disease; SFA, superficial femoral artery
Recommendation Grading
Strength of Recommendation Level of Evidence
1 – Strong Benefit clearly outweighs risk A High
2 – Weak Benefits and risks are more closely matched and
are more dependent on specific clinical scenarios
B Moderate
C Low
U Ungraded
